Examination of the Effectiveness of Diffusion Weighted Magnetic Resonance Imaging for Identifying Poor Prognosis in Patients With Rheumatoid Arthritis

NCT01482507 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2018-04-06

No results posted yet for this study

Summary

Diffusion Weighted Imaging (DWI) MRI will assist in differentiating poor prognosis bone oedema more effectively than traditional T2 weighted MRI in patients with early Rheumatoid Arthritis (RA).

Conditions

Sponsors & Collaborators

  • Arthritis Australia, Abbott Australia

    collaborator UNKNOWN
  • Optimus Clinical Research

    lead OTHER

Principal Investigators

  • Paul Bird, Dr · Optimus Clinical Research

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01482507 on ClinicalTrials.gov